{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:11:16Z","timestamp":1792030276705,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 La Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201821-30"],"award-info":[{"award-number":["201821-30"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","award":["20026"],"award-info":[{"award-number":["20026"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Robert Koch-Institute through funds of the Federal Ministry of Health","award":["1369-341"],"award-info":[{"award-number":["1369-341"]}]},{"name":"CJD Foundation","award":["Implementation of a blood-based biomarker test for sporadic Creutzfeldt-Jakob in clinical practice"],"award-info":[{"award-number":["Implementation of a blood-based biomarker test for sporadic Creutzfeldt-Jakob in clinical practice"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s12035-022-02891-7","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T06:02:33Z","timestamp":1655532153000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5502-681X","authenticated-orcid":false,"given":"Matthias","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezgi","family":"Canaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Fern\u00e1ndez-Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Villar-Piqu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc","family":"Llorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Varges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Maass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Maria","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,18]]},"reference":[{"key":"2891_CR1","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/PNAS.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci 95:13363\u201313383. https:\/\/doi.org\/10.1073\/PNAS.95.23.13363","journal-title":"Proc Natl Acad Sci"},{"key":"2891_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1212\/wnl.58.2.192","volume":"58","author":"M Otto","year":"2002","unstructured":"Otto M, Wiltfang J, Cepek L et al (2002) Tau protein and 14\u20133-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58:192\u2013197. https:\/\/doi.org\/10.1212\/wnl.58.2.192","journal-title":"Neurology"},{"key":"2891_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9133-2","author":"M Cramm","year":"2016","unstructured":"Cramm M, Schmitz M, Karch A et al (2016) Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-015-9133-2","journal-title":"Mol Neurobiol"},{"key":"2891_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.120","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Cramm M, Llorens F et al (2016) The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nat Protoc. https:\/\/doi.org\/10.1038\/nprot.2016.120","journal-title":"Nat Protoc"},{"key":"2891_CR5","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s12035-015-9167-5","volume":"53","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Ebert E, Stoeck K et al (2016) Validation of 14\u20133-3 protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic. Mol Neurobiol 53:2189\u20132199. https:\/\/doi.org\/10.1007\/s12035-015-9167-5","journal-title":"Mol Neurobiol"},{"key":"2891_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","volume":"67","author":"P Sanchez-Juan","year":"2006","unstructured":"Sanchez-Juan P, Green A, Ladogana A et al (2006) CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 67:637\u2013643. https:\/\/doi.org\/10.1212\/01.wnl.0000230159.67128.00","journal-title":"Neurology"},{"key":"2891_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13195-021-00815-6","volume":"13","author":"I Zerr","year":"2021","unstructured":"Zerr I, Villar-Piqu\u00e9 A, Hermann P et al (2021) Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease. Alzheimers Res Ther 13:86. https:\/\/doi.org\/10.1186\/s13195-021-00815-6","journal-title":"Alzheimers Res Ther"},{"key":"2891_CR8","doi-asserted-by":"publisher","unstructured":"Steinacker P, Blennow K, Halbgebauer S et al (2016) Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease. Sci Rep 6 https:\/\/doi.org\/10.1038\/SREP38737","DOI":"10.1038\/SREP38737"},{"key":"2891_CR9","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/JNNP-2017-317793","volume":"89","author":"AGB Thompson","year":"2018","unstructured":"Thompson AGB, Luk C, Heslegrave AJ et al (2018) Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression. J Neurol Neurosurg Psychiatry 89:955\u2013961. https:\/\/doi.org\/10.1136\/JNNP-2017-317793","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2891_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1474-4422(19)30403-X","volume":"19","author":"SM Vallabh","year":"2020","unstructured":"Vallabh SM, Minikel EV, Schreiber SL, Lander ES (2020) Towards a treatment for genetic prion disease: trials and biomarkers. Lancet Neurol 19:361\u2013368. https:\/\/doi.org\/10.1016\/S1474-4422(19)30403-X","journal-title":"Lancet Neurol"},{"key":"2891_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1641","author":"DM Rissin","year":"2010","unstructured":"Rissin DM, Kan CW, Campbell TG et al (2010) Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol. https:\/\/doi.org\/10.1038\/nbt.1641","journal-title":"Nat Biotechnol"},{"key":"2891_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s004399900124","volume":"105","author":"O Windl","year":"1999","unstructured":"Windl O, Giese A, Schulz-Schaeffer W et al (1999) Molecular genetics of human prion diseases in Germany. Hum Genet 105:244\u2013252. https:\/\/doi.org\/10.1007\/s004399900124","journal-title":"Hum Genet"},{"key":"2891_CR13","unstructured":"Who (1998) Human transmissible spongiform encephalopathies. Wkly Epidemiol Rec 73:361\u2013365"},{"key":"2891_CR14","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132:2659\u20132668. https:\/\/doi.org\/10.1093\/brain\/awp191","journal-title":"Brain"},{"key":"2891_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","volume":"20","author":"P Hermann","year":"2021","unstructured":"Hermann P, Appleby B, Brandel J-P et al (2021) Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol 20:235\u2013246. https:\/\/doi.org\/10.1016\/S1474-4422(20)30477-4","journal-title":"Lancet Neurol"},{"key":"2891_CR16","unstructured":"Who (2003) WHO Manual for Surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease. Communicable disease surveillance and response. World Health Organisation Genova, 51\u201359"},{"key":"2891_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/1531-8249(200009)48:3<323::AID-ANA6>3.0.CO;2-5","volume":"48","author":"I Zerr","year":"2000","unstructured":"Zerr I, Schulz-Schaeffer WJ, Giese A et al (2000) Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 48:323\u2013329","journal-title":"Ann Neurol"},{"key":"2891_CR18","doi-asserted-by":"crossref","unstructured":"Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementiaassociated with Parkinson' disease. Mov Disord 22(12):1689\u2013707","DOI":"10.1002\/mds.21507"},{"key":"2891_CR19","doi-asserted-by":"crossref","unstructured":"McKeith IG, Boeve BF, DIckson D et al (2017) Diagnosis and management of dementia with Lewy bodies. Neurology 89(1):88\u2013100","DOI":"10.1212\/WNL.0000000000004058"},{"key":"2891_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","volume":"163","author":"S Gilman","year":"1999","unstructured":"Gilman S, Low PA, Quinn N et al (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163:94\u201398. https:\/\/doi.org\/10.1016\/S0022-510X(98)00304-9","journal-title":"J Neurol Sci"},{"key":"2891_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676. https:\/\/doi.org\/10.1212\/01.wnl.0000324625.00404.15","journal-title":"Neurology"},{"key":"2891_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2017.09.007","volume":"14","author":"OA Skrobot","year":"2018","unstructured":"Skrobot OA, Black SE, Chen C et al (2018) Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement 14:280\u2013292. https:\/\/doi.org\/10.1016\/j.jalz.2017.09.007","journal-title":"Alzheimers Dement"},{"key":"2891_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"key":"2891_CR24","doi-asserted-by":"publisher","first-page":"e1001319","DOI":"10.1371\/journal.ppat.1001319","volume":"7","author":"D Padilla","year":"2011","unstructured":"Padilla D, B\u00e9ringue V, Espinosa JC et al (2011) Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice. PLoS Pathog 7:e1001319. https:\/\/doi.org\/10.1371\/journal.ppat.1001319","journal-title":"PLoS Pathog"},{"key":"2891_CR25","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3201\/eid2309.161948","volume":"23","author":"N Fern\u00e1ndez-Borges","year":"2017","unstructured":"Fern\u00e1ndez-Borges N, Espinosa JC, Mar\u00edn-Moreno A et al (2017) Protective effect of Val(129)-PrP against bovine spongiform encephalopathy but not variant Creutzfeldt-Jakob disease. Emerg Infect Dis 23:1522\u20131530. https:\/\/doi.org\/10.3201\/eid2309.161948","journal-title":"Emerg Infect Dis"},{"key":"2891_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32\u201335. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1%3c32::aid-cncr2820030106%3e3.0.co;2-3","journal-title":"Cancer"},{"key":"2891_CR27","doi-asserted-by":"publisher","first-page":"717930","DOI":"10.3389\/fnagi.2021.717930","volume":"13","author":"S Canaslan","year":"2021","unstructured":"Canaslan S, Schmitz M, Villar-Piqu\u00e9 A et al (2021) Detection of cerebrospinal fluid neurofilament light chain as a marker for alpha-synucleinopathies. Front Aging Neurosci 13:717930. https:\/\/doi.org\/10.3389\/fnagi.2021.717930","journal-title":"Front Aging Neurosci"},{"key":"2891_CR28","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1002\/mds.28724","volume":"36","author":"M Schmitz","year":"2021","unstructured":"Schmitz M, Canaslan S, Villar-Piqu\u00e9 A et al (2021) Validation of plasma neurofilament light chain as a marker for \u03b1-synucleinopathies. Mov Disord 36:2701\u20132703","journal-title":"Mov Disord"},{"key":"2891_CR29","doi-asserted-by":"publisher","first-page":"11034","DOI":"10.1038\/s41598-021-90639-z","volume":"11","author":"P Altmann","year":"2021","unstructured":"Altmann P, Ponleitner M, Rommer PS et al (2021) Seven day pre-analytical stability of serum and plasma neurofilament light chain. Sci Rep 11:11034. https:\/\/doi.org\/10.1038\/s41598-021-90639-z","journal-title":"Sci Rep"},{"issue":"8","key":"2891_CR30","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P et al (2019) Neurofilament light chain as a biomarker in neurological disorders. Neurol Neurosurg Psychiatry 90(8):870\u2013881","journal-title":"Neurol Neurosurg Psychiatry"},{"key":"2891_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14612-6","author":"M Khalil","year":"2020","unstructured":"Khalil M, Pirpamer L, Hofer E et al (2020) Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-020-14612-6","journal-title":"Nat Commun"},{"key":"2891_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13195-017-0331-1","volume":"10","author":"S Abu-Rumeileh","year":"2018","unstructured":"Abu-Rumeileh S, Capellari S, Stanzani-Maserati M et al (2018) The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias. Alzheimers Res Ther 10:3. https:\/\/doi.org\/10.1186\/s13195-017-0331-1","journal-title":"Alzheimers Res Ther"},{"key":"2891_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jocn.2018.09.031","volume":"60","author":"E Kanata","year":"2019","unstructured":"Kanata E, Golanska E, Villar-Piqu\u00e9 A et al (2019) Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease. J Clin Neurosci Off J Neurosurg Soc Australas 60:124\u2013127. https:\/\/doi.org\/10.1016\/j.jocn.2018.09.031","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"2891_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jalz.2017.12.008","volume":"14","author":"I Zerr","year":"2018","unstructured":"Zerr I, Schmitz M, Karch A et al (2018) Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: evaluation of diagnostic accuracy in the differential diagnosis of prion diseases. Alzheimers Dement 14:751\u2013763. https:\/\/doi.org\/10.1016\/j.jalz.2017.12.008","journal-title":"Alzheimers Dement"},{"key":"2891_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1313-4","author":"M Schmitz","year":"2019","unstructured":"Schmitz M, Villar-Piqu\u00e9 A, Llorens F et al (2019) Cerebrospinal fluid total and phosphorylated \u03b1-synuclein in patients with Creutzfeldt-Jakob disease and synucleinopathy. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-018-1313-4","journal-title":"Mol Neurobiol"},{"key":"2891_CR36","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.1038\/S41380-021-01045-W","volume":"26","author":"AGB Thompson","year":"2021","unstructured":"Thompson AGB, Anastasiadis P, Druyeh R et al (2021) Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases. Mol Psychiatry 26:5955\u20135966. https:\/\/doi.org\/10.1038\/S41380-021-01045-W","journal-title":"Mol Psychiatry"},{"key":"2891_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2174\/1871526510909010092","volume":"9","author":"I Zerr","year":"2009","unstructured":"Zerr I (2009) Therapeutic trials in human transmissible spongiform encephalo-pathies: recent advances and problems to address. Infect Disord Drug Targets 9:92\u201399. https:\/\/doi.org\/10.2174\/1871526510909010092","journal-title":"Infect Disord Drug Targets"},{"key":"2891_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/ENE.15302","author":"P Hermann","year":"2022","unstructured":"Hermann P, Canaslan S, Villar-Piqu\u00e9 A et al (2022) Plasma neurofilament light chain as a biomarker for fatal familial insomnia. Eur J Neurol. https:\/\/doi.org\/10.1111\/ENE.15302","journal-title":"Eur J Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-02891-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-022-02891-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-02891-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T15:17:26Z","timestamp":1661181446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-022-02891-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,18]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["2891"],"URL":"https:\/\/doi.org\/10.1007\/s12035-022-02891-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,18]]},"assertion":[{"value":"11 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conformed to the Code of Ethics of the World Medical, approved by the local ethics committee in G\u00f6ttingen 24\/8\/12, \u201cBiomarker-based Diagnosis of rapidly progressive dementias \u2013 optimization of diagnostic protocols.\u201d Informed consent was obtained from all subjects involved in the study. All animal experiments are carried out following the Spanish guidelines by Directive 2010\/63\/EU of the European Union and made every effort to minimize suffering. Animal experiments were evaluated by the Committee on the Ethics of Animal Experiments of the Instituto Nacional de Investigaci\u00f3n y Tecnolog\u00eda Agraria y Alimentaria and approved by the General Directorate of the Madrid Community Government (permit no. PROEX 094\/18 and PROEX 291\/19).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent to participate in the study was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Informed consent for publication was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The research involves human and animal samples.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and\/or Animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}